This invitation-only conference offers networking opportunities, product showcases, insightful client success stories, and thought-provoking sessions featuring Trial Interactive experts and industry-leading guest speakers.
Designed with the Trial Interactive user in mind, the agenda includes opportunities to interface with our experts and ask your most burning questions. Come interact with your peers and help drive the evolution of Trial Interactive.
Don’t miss out on the chance to attend the OpTImize Summit. Secure your spot and be part of shaping the future of your eClinical solutions.
Bonus Access to GlobalLink NEXT
All OpTImize London attendees will receive complimentary access to GlobalLink NEXT, TransPerfect’s annual, invitation-only conference for industry leaders, tech innovators, and global users.
This two-day event features product spotlights, interactive sessions, and unmatched networking opportunities. From AI and localization to global content strategy and digital transformation, GlobalLink NEXT is where forward-thinking teams gather to shape what’s next.
Meet the TI Team
Interested in seeing last year's panel discussions?
Watch our 2024 opTImize panel discussions.
Speakers











Agenda
Agenda and timing of sessions are subject to change
9:30 - 12:00
1:1 Meetings
12:00 - 13:30
Registration and Networking Lunch with GLNXT
13:30 - 13:45
Opening Remarks
13:45 - 14:15
Intelligent Performance
14:15 - 14:30
Welcome to GlobalLink Live
14:30 - 14:45
Break
14:45 - 15:30
ICH E6(R3) and Industry Updates
With the release of ICH E6(R3), clinical trials are entering a new era of expectations around data integrity, quality by design, and risk-based approaches. This session will examine the key changes introduced in R3 and how they’re impacting sponsor responsibilities, technology use, and inspection readiness. Gillian will also provide an update on the development of version 4 of the TMF Reference Model, which is being revised to meet the needs of today’s digital landscape.

15:30 -16:00
Sponsor Oversight Through the eTMF
In this keynote session, Laurel-Ann Schrader will explore how sponsors can leverage the eTMF as a strategic tool for oversight, inspection readiness, and compliance. She’ll outline regulatory expectations from global agencies, including the MHRA, EMA, and FDA. Drawing on her real-world experience leading the Trial Interactive client solutions team—where she supports inspection readiness and audit preparedness—Laurel-Ann will highlight how proactive eTMF management can help sponsors mitigate risk and maintain a state of audit-readiness every day.

16:00 - 16:30
Proactive Quality: From Oversight to Action
It’s more essential than ever to ensure quality at every stage of today’s clinical trials. This session explores how sponsors and CROs can elevate quality management through real-time quality reviews, CAPA tracking, and integrated training strategies. Learn how centralized oversight, site collaboration, and smart automation can reduce risk, improve inspection readiness, and drive continuous improvement across studies.



16:30 -16:50
Break
16:50 - 17:50
Keynote Speaker
17:50 - 18:00
Closing Remarks
18:00 - 19:00
Networking Reception
19:30 - 22:30
Evening Social Event at Sea Containers
8:00 - 9:30
1:1 Meetings, Registration, Breakfast
9:00 - 9:45
Breaking Down Silos: Cross-Functional Collaboration for TMF Success
Achieving TMF excellence requires seamless collaboration across teams like Clinical, Regulatory, Data Management, and Quality. In this panel, industry experts will share insights on breaking down silos, fostering communication, and aligning cross-functional priorities to ensure TMF completeness, compliance, and inspection readiness. Learn practical strategies for improving teamwork, streamlining documentation processes, and leveraging technology to create a truly collaborative TMF environment.

Gillian Gittens, Director of eClinical Strategy and Solutions, is a TMF industry veteran with over 25 years’ experience. Gill has a wealth of insight and expertise in managing TMF services and delivering ongoing customer success across all aspects of TMF operations. A member of the CDISC TMF Reference Model Steering Committee and Project Management Team leading the V4 initiative, Gill has key expertise and insight in industry best practice, regulatory guidance and the future of TMF management.

On the journey from paper TMF to eTMF, supporting clinical studies across IMPs, medical devices, cosmetics, and general products.

Karla Navera-Andersen is a Senior eTMF Manager at Zealand Pharma with nearly 17 years of experience in TMFs. She holds a Master of Arts in English and a Pharma Consultant Diploma. Karla began her career in a paper TMF archive and has since worked on both the CRO and sponsor sides, across Clinical Operations and Regulatory Affairs. She leverages her broad industry experience to drive stakeholder engagement, foster cross-functional alignment, and simplify the complexities of eTMF.
9:45 - 10:30
Unlocking Clinical Trial Visibility with CTMS
Clinical trials generate large volumes of data, tasks, and timelines. Without centralized oversight, studies can quickly veer off track. This session explores how modern CTMS solutions consolidate workflows into a single source of truth. Discover how enhanced visibility and automation can accelerate decision-making, reduce risk, and improve overall trial performance.

Michael Smyth has 30+ years of experience working in the pharmaceutical clinical development industry across sponsors and CROs. Michael, fueled by, his passion consults with our pharmaceutical, biotechnology, medical device, and CRO clients to determine how to most efficiently use our Trial Interactive platform to streamline clinical development processes for all stakeholders. Smyth is an active member of the Drug Information Association and frequent blogger on all things focused on improving the entire clinical trial landscape to bring products to market faster.
10:30 - 10:45
Break
10:45 - 11:00
AI in Medical Writing - Content Creation for 2025
Generative AI is transforming the commercial landscape for life sciences organizations, enhancing everything from medical writing to multilingual content creation. This session will showcase real-world applications of AI across key functions, including medical communications, e-learning, digital content, product support, and pharmacovigilance. Through data-driven examples, we’ll demonstrate how AI is accelerating timelines, reducing costs, and improving engagement—such as a 50% reduction in scientific publication QA time and a 45% increase in training engagement. Whether you’re developing global campaigns or managing complex product information, discover how AI is delivering measurable value across the life sciences space—and what steps your organization can take next.

Kelsey Brown spearheads TransPerfect’s Medical Writing division, bringing together strategic content creation and technology to develop high‑impact materials across preclinical, clinical, and commercial. Kelsey’s 10+ years of expertise includes clinical research and development, medical affairs, data transparency, and health literacy. Previous to joining TransPerfect in 2018, Kelsey worked in medical writing both in the sponsor and CRO worlds. With deep expertise in scientific communication and a passion for empowering patients, Kelsey combines analytical insight with empathetic leadership.

Henry has been supporting clinical activity across the pharmacovigilance, CRO, and now TMF FSP space for 12 years; and has supported 50+ eTMF implementations and 30 FSP model activations in the last 18 months. Working across multiple support models, he remains a market leading expert in adaptable compliant workflows for full TMF compliance. He works directly with sponsors, providing full TMF management, alongside CROs as a collaborative partner, and advises on appropriate technology platforms and configurations based on client need. He also sits at the forefront of the TransPerfect AI rollout, helping with AI for TMF Management, eCTD Submissions, and Medical Writing.
11:00 - 11:45
The Future of TMF: AI Driven Quality Assurance, Insights, and Automations (Automate)
Artificial intelligence is fundamentally changing TMF management, introducing powerful tools for quality assurance, oversight, and compliance. This panel will dive into AI-powered TMF automation and how it transforms TMF processes. Learn how organizations are leveraging AI tools like Trial Interactive Automate to identify risks, streamline document classification, and enhance real-time insights, ultimately driving greater efficiency and regulatory readiness.

Katherine Cianciarelli is a senior product manager with almost a decade of experience in eClinical technology. An engineer by trade, she focuses on building practical AI tools that improve clinical research workflows. Her work centers on finding smart ways to optimize processes while ensuring responsible and compliant technology use, always seeking to bridge the gap between technical innovation and real-world research needs.

Sylwia brings over 10 years of experience in clinical trials and Trial Master File (TMF) management. Her career spans roles at a CRO, a TMF vendor, and on the sponsor side, giving her a well-rounded perspective. She is proficient in four TMF systems and is currently leading the implementation of an AI tool to enhance TMF management processes.
11:45 - 12:15
Migrate with Confidence – Technical Migration and Archival Strategies for Completeness
Take the difficulty out of migrations with careful planning, technical expertise, and a clear understanding of regulatory expectations. This session will focus on the technical aspects of TMF migration, including metadata mapping, document integrity checks, system compatibility, and audit trail preservation. Attendees will learn best practices for executing a smooth, validated migration that ensures completeness, accuracy, and ongoing compliance with GCP. Whether you’re preparing for a system upgrade, transitioning vendors, or centralizing legacy data, this session will help you do it right—the first time.

Lisa entered the pharmaceutical industry in 2001 and moved into clinical research in 2006, supporting trials across various therapeutic areas at CROs. In 2009, she transitioned to the vendor side, helping global pharmaceutical clients implement eTMF and providing ongoing services. She now leads the professional services team, focusing on document services and leveraging her expertise in inspection readiness, TMF QC, document destruction, and archiving. Lisa is based in our London office.

Ameena holds a master’s degree in biomedical Methods and Technology from Malmö University and brings over 15 years of pharmaceutical industry experience. Her expertise spans system implementation, validation, audits, compliance, and TMF oversight. Ameena began her TMF career at Data Reduction Systems in New Jersey and has continued to grow her leadership in the field. For the past six years at Zealand Pharma A/S, she has worked alongside cross-functional teams to advance system capabilities and support the evolving needs of clinical operations.

Since November 2021, Anita Thomas has been serving as a Documentation Specialist at Priothera SAS in Saint-Louis, France. Her previous roles include TMF Manager for Outsourced Studies at Novartis (2020–2021) and Clinical Trial Documentation Manager at Santhera (2017–2021), both based in Switzerland. Anita also held positions such as Trial Documentation Specialist at Actelion, ESOPs Reviewer at Novartis, and Technical Writer at Roche. Earlier in her career, she worked as a Business Process Coordinator at Roche, SUSAR Submissions Coordinator and Clinical Trial Administrator at Actelion, and Clinical Trial Associate at Hesperion Ltd, building deep expertise in clinical documentation and operations.
12:15 - 13:15
Networking Lunch
13:15 - 14:00
Powering Site Partnerships Through Collaboration and Tech
Gain firsthand insights from site representatives as they discuss strategies for overcoming common challenges in study start-up, ongoing trial management, and study close-out. Learn how sites navigate regulatory hurdles, streamline workflows, and enhance collaboration to drive trial success.

Jay leads the design and development of product features and capabilities for Trial Interactive. With over 25 years of experience in product management, consulting, and engineering, he has worked across life sciences, enterprise software, healthcare, government, entertainment, and manufacturing. Before TransPerfect, Jay led cloud migration initiatives at Medidata and Sparta Systems and managed solutions including clinical portals, eTMF, CTMS, RTSM, EDC, and grants. He has also built products for eCTD submissions, quality and document management, computer validation, and mobile apps for physicians, sales teams, and consumers.

Katrin Simioni is the Deputy Head of Clinical Operations at the AO Foundation, a global leader in education, research, and innovation in musculoskeletal trauma care. She holds a PhD from ETH Zurich and the University of Zurich and has over 10 years of experience managing international clinical studies and leading AO’s multidisciplinary operations team. Katrin is committed to advancing technological innovation in clinical research, ensuring AO remains at the forefront and continues to attract world-class surgeons in support of its mission.

An experienced Senior CRA, the founder of Monocytes launched the company with a mission to enhance site performance and data quality in clinical trials by preventing common errors—much like monocyte cells protect and improve health in the body.
14:00 - 14:45
Inspection Readiness Prep: From GCP Correction to Quality Issue Management
Study reconstruction is often seen as a last-resort effort, but it’s a vital part of ensuring GCP compliance and inspection readiness. This session will clarify what study reconstruction truly involves and how it can be approached strategically. Experts from Trial Interactive’s TMF Services team will walk through each component, including how to identify missing or non-compliant documentation, issue GCP corrections, log quality issues appropriately, and align with audit expectations. Learn how proactive TMF oversight and a structured reconstruction process can not only salvage a trial, but also strengthen your organization’s long-term quality management systems.




14:45 - 15:15
TMF Management: View from the CROs
When sponsors rely on CROs to manage critical TMF activities, effective oversight and organizational alignment are essential. In this session, CRO leaders will share their perspectives on TMF management—highlighting strategies to meet sponsor expectations, maintain inspection readiness, and adapt to evolving regulatory requirements. The discussion will explore best practices for collaboration, the importance of clearly defined roles and responsibilities, and how CROs and sponsors can work together to reduce risk and elevate quality.

Michael Smyth has 30+ years of experience working in the pharmaceutical clinical development industry across sponsors and CROs. Michael, fueled by, his passion consults with our pharmaceutical, biotechnology, medical device, and CRO clients to determine how to most efficiently use our Trial Interactive platform to streamline clinical development processes for all stakeholders. Smyth is an active member of the Drug Information Association and frequent blogger on all things focused on improving the entire clinical trial landscape to bring products to market faster.

Graham brings extensive experience across pharmaceutical, biotech, and CRO organizations. With a career that began as a statistician in the UK, he has held leadership roles in the US, Germany, and the UK, overseeing global teams across statistics, data management, programming, EDC, medical writing, and more. Graham is passionate about driving operational excellence, digital transformation, and cross-functional growth within clinical development. He joined MAC in mid-2024, where he continues to lead innovation in biometrics and beyond.
15:15-15:30
Closing Remarks
15:30-17:00
1:1 Meetings and Networking Event
FAQ
Is this event free?
Yes, there is no registration fee associated with this event. However, spots are limited.
Who is this event for?
OpTImize is for more than just TransPerfect and Trial Interactive clients! The summit is geared toward executives, directors, and senior managers within the clinical trial industry. Spaces are limited and will be prioritized accordingly, therefore eligibility is subject to approval by the TransPerfect Trial Interactive team.
Do I have to attend both days?
No, registration covers both days, but we understand some people can only attend one day of sessions.
I have more questions, who do I contact?
Email optimize@transperfect.com with any additional questions.
9:30-12:00
1:1 Meetings
12:00-13:30
Intelligent Performance
13:45-14:15
Welcome to GlobalLink Live
14:30-14:45
Break
14:45-15:30
ICH E6(R3) and Industry Updates
With the release of ICH E6(R3), clinical trials are entering a new era of expectations around data integrity, quality by design, and risk-based approaches. This session will examine the key changes introduced in R3 and how they’re impacting sponsor responsibilities, technology use, and inspection readiness. Gillian will also provide an update on the development of version 4 of the TMF Reference Model, which is being revised to meet the needs of today’s digital landscape.
15:30-16:00
Sponsor Oversight Through the eTMF
In this keynote session, Laurel-Ann Schrader will explore how sponsors can leverage the eTMF as a strategic tool for oversight, inspection readiness, and compliance. She’ll outline regulatory expectations from global agencies, including the MHRA, EMA, and FDA. Drawing on her real-world experience leading the Trial Interactive client solutions team—where she supports inspection readiness and audit preparedness—Laurel-Ann will highlight how proactive eTMF management can help sponsors mitigate risk and maintain a state of audit-readiness every day.
16:00-16:30
TMF Management: View from the CROs
When sponsors rely on CROs to manage critical TMF activities, effective oversight and organizational alignment are essential. In this session, CRO leaders will share their perspectives on TMF management—highlighting strategies to meet sponsor expectations, maintain inspection readiness, and adapt to evolving regulatory requirements. The discussion will explore best practices for collaboration, the importance of clearly defined roles and responsibilities, and how CROs and sponsors can work together to reduce risk and elevate quality.